BioCentury
ARTICLE | Distillery Therapeutics

Inflammation; neurology

April 17, 2018 9:09 PM UTC

Mouse and non-human primate studies suggest the σ receptor activator T-817MA could help treat traumatic brain injury (TBI) and stroke. In a mouse model of TBI, oral T-817MA increased motor function compared with vehicle. In a macaque model of stroke, T-817MA increased motor function. Next steps by the Toyama Chemical Co. Ltd. subsidiary of Fujifilm Holdings Corp. include a clinical trial of T-817MA in stroke patients...